Patients with sickle cell disease who have strokes can be safely treated with tissue plasminogen activator, according to a study by Medical University of South Carolina researchers. The findings were based on data for 2,016,652 patients treated in hospitals from 2008 to 2015, and no significant differences were seen in rates of tPA use or in-hospital complications.
Immucor Launches NEW Validation Panel! Validating a new blood bank instrument? As part of our commitment to the blood bank industry, Immucor is pleased to announce the availability of a new Validation Panel to supplement your validation studies. Let us help ease the burden of sourcing those difficult to find positive antibody screen samples! For more information please call 800.855.IMMUCOR. Click Here.
Of 43 infants with Zika-related microcephaly in Colombia and Venezuela, 88% and 12% developed macular or optic nerve abnormalities and congenital glaucoma, respectively, according to a study in JAMA Ophthalmology. The results should prompt evaluations for ophthalmic findings for all babies with Zika-linked microcephaly, researchers said.
The European Research Council has awarded a grant worth $2.7 million to a Goethe University Frankfurt scientist. Ivan Dikic is examining the role the ubiquitin system has in bacterial infections in order to develop new ways to fight infectious diseases.
GenDx has reached an agreement with South Korean firm Infopia to distribute Infopia's GeneFinder human leukocyte antigen real-time PCR assays in Europe for undisclosed terms. GenDx will sell the kits through its local distributor network.
The World Health Organization is finalizing a global vector control plan for approval by the World Health Assembly in May. The plan is focused on densely urban areas that can be breeding grounds for Aedes mosquitoes.
The treatment of pediatric patients often requires specific care that may differ from the treatment of adult patients. The April issue of "AABB News" focuses on pediatric care -- specifically as it relates to the fields of transfusion medicine and cellular therapies. Four articles written by AABB members with expertise in pediatric care highlight various aspects of pediatric transfusion medicine and cellular therapies. The topics include the use of technology to improve patient care, red blood cell transfusions in neonates, clinical data in pediatric transfusion medicine and pediatric patient blood management.